HomepageSTIM • NASDAQ
add
Neuronetics Inc
$ 1,45
Na sluitingstijd:(0,69%)-0,0100
$ 1,44
Gesloten: 4 dec, 17:20:00 GMT-5 · USD · NASDAQ · Disclaimer
Vorige slotkoers
$ 1,34
Dag-range
$ 1,32 - $ 1,51
Jaar-range
$ 1,00 - $ 5,91
Beurswaarde
99,30 mln. USD
Gem. volume
2,03 mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 37,30 mln. | 101,28% |
Bedrijfskosten | 24,43 mln. | 12,43% |
Netto inkomsten | -9,04 mln. | 32,20% |
Netto winstmarge | -24,25 | 66,32% |
Winst per aandeel | -0,13 | 70,45% |
EBITDA | -6,44 mln. | 10,82% |
Effectief belastingtarief | — | — |
Balans
Totale activa
Totale passiva
| (USD) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 27,97 mln. | 34,04% |
Totale activa | 145,46 mln. | 96,26% |
Totale passiva | 114,10 mln. | 76,26% |
Totaal aandelenvermogen | 31,36 mln. | — |
Uitstaande aandelen | 68,49 mln. | — |
Koers-boekwaardeverhouding | 3,35 | — |
Rendement op activa | -13,07% | — |
Rendement op kapitaal | -15,62% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -9,04 mln. | 32,20% |
Operationele kasstroom | -785,00K | 85,51% |
Kasstroom uit beleggingen | -114,00K | -914,29% |
Kasstroom uit financiering | 17,90 mln. | 209,34% |
Nettomutatie in liquide middelen | 17,00 mln. | 178,08% |
Vrije kasstroom | 5,35 mln. | 287,96% |
Over
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
Opgericht
2003
Hoofdvestiging
Website
Werknemers
716
